In line with our findings, Baccelli et al. provided direct evidence on the metastatic potential of CTCs expressing CD47, among other markers [8], and demonstrated CD47 expression in CTCs detected in a small cohort of metastatic BC patients [9]. This evidence concerns the gene CD47 and breast cancer.